National Β· Lead Story
FDA-Approved Synthetic THC Left Seniors More Likely to Quit. Real Cannabis Kept Them in the Study β and in Less Pain.
A 24-week German study of 484 patients 65 and older found that plant-derived cannabis outperformed FDA-approved synthetic THC on every measure β pain, sleep, quality of life, and dropout rates. American patients can’t get easy access to either.
